GlycoNet researchers have developed specialized nanobodies that could enable the immune system to fight triple-negative breast cancer more effectively.
Tag: breast cancer
Drs. Karla Williams, Ann Chambers, and two GlycoNet scientists Drs. Mark Nitz and Hon Leong—received a US$600,000 award from the U.S. Department of Defense (DoD) to expand their breast cancer research.